Tumor-to-liver ratio (TLR) by 68Ga-PSMA-11 PET/CT for response assessment and prediction of progressionfree survival in patients with mCRPC undergoing 177Lu-PSMA-617 radioligand therapy

被引:0
|
作者
Khreish, F. [1 ]
Wiessner, M. [1 ]
Rosar, F. [1 ]
Ghazal, Z. [1 ]
Sabet, A. [2 ]
Maus, S. [1 ]
Linxweiler, J. [3 ]
Bartholomae, M. [1 ]
Ezziddin, S. [1 ]
机构
[1] Saarland Univ, Dept Nucl Med, Homburg, Germany
[2] Frankfurt Univ, Dept Nucl Med, Frankfurt, Germany
[3] Saarland Univ, Dept Urol, Homburg, Germany
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-0900
引用
收藏
页码:S314 / S314
页数:1
相关论文
共 50 条
  • [31] A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma
    Guochang Wang
    Mengjiao Zhou
    Jie Zang
    Yuanyuan Jiang
    Xiaohong Chen
    Zhaohui Zhu
    Xiaoyuan Chen
    EJNMMI Research, 12
  • [32] A pilot study of 68Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma
    Wang, Guochang
    Zhou, Mengjiao
    Gao, Hongbo
    Zang, Jie
    Jiang, Yuanyuan
    Wang, Rongxi
    Shao, Yujun
    Chen, Xiaohong
    Zhu, Zhaohui
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [33] A pilot study of 68 Ga-PSMA-617 PET/CT imaging and 177Lu-EB-PSMA-617 radioligand therapy in patients with adenoid cystic carcinoma
    Wang, Guochang
    Zhou, Mengjiao
    Zang, Jie
    Jiang, Yuanyuan
    Chen, Xiaohong
    Zhu, Zhaohui
    Chen, Xiaoyuan
    EJNMMI RESEARCH, 2022, 12 (01)
  • [34] Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy
    Rosar, Florian
    Wenner, Felix
    Khreish, Fadi
    Dewes, Sebastian
    Wagenpfeil, Gudrun
    Hoffmann, Manuela A.
    Schreckenberger, Mathias
    Bartholoma, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (05) : 1584 - 1594
  • [35] Early molecular imaging response assessment based on determination of total viable tumor burden in [68Ga]Ga-PSMA-11 PET/CT independently predicts overall survival in [177Lu]Lu-PSMA-617 radioligand therapy
    Florian Rosar
    Felix Wenner
    Fadi Khreish
    Sebastian Dewes
    Gudrun Wagenpfeil
    Manuela A. Hoffmann
    Mathias Schreckenberger
    Mark Bartholomä
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 1584 - 1594
  • [36] The effect of tumor burden in 68GA-PSMA-PET/CT on tracer uptake into kidneys in 68Ga-PSMA-PET/CT and the absorbed dose per administered GBq 177Lu-PSMA-617 during a following therapy
    Wichert, J.
    Happel, C.
    Kranert, W. T.
    Groener, D.
    Baumgarten, J.
    Ngoc, C. Nguyen
    Mader, N.
    Banek, S.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S423 - S424
  • [37] Investigation of [177Lu]Lu-PSMA-617 therapy minimum cycle interval with [68Ga]Ga-PSMA-11 PET/CT
    Costa, G.
    Yousefzadeh-Nowshahr, E.
    Orlov, C.
    Fitzpatrick, K.
    Frey, K.
    Beer, A.
    Dewaraja, Y.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S210 - S210
  • [38] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [39] Baseline [68Ga]Ga-PSMA-11 PET/CT before [177Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions
    Groener, Daniel
    Schneider, Sina
    Baumgarten, Justus
    Happel, Christian
    Klimek, Konrad
    Mader, Nicolai
    Ngoc, Christina Nguyen
    Wichert, Jennifer
    Mandel, Philipp
    Tselis, Nikolaos
    Gruenwald, Frank
    Sabet, Amir
    CANCERS, 2023, 15 (02)
  • [40] Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival
    Kurth, Jens
    Kretzschmar, Justus
    Aladwan, Hamzeh
    Heuschkel, Martin
    Gummesson, Anja
    Bergner, Carina
    Kundt, Guenther
    Hakenberg, Oliver W.
    Krause, Bernd J.
    Schwarzenboeck, Sarah M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (11) : 1217 - 1226